Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nelson Castro

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
American Journal of Hematology|May 23, 2022
Isatuximab plus carfilzomib and dexamethasone in patients with relapsed multiple myeloma based on prior lines of treatment and refractory status: IKEMA subgroup analysisMeletios A Dimopoulos, Philippe Moreau, Bradley Augustson, et al.
Ejhaem|November 29, 2023
Treatment outcomes in classic Hodgkin lymphoma: 5-year update from the Brazilian Hodgkin Lymphoma RegistryIrene Biasoli, Nelson Castro, Carolina Colaço Villarim, et al.
British Journal of Haematology|October 17, 2024
External validation and calibration of the HoLISTIC Consortium's advanced-stage Hodgkin lymphoma international prognostic index (A-HIPI) in the Brazilian Hodgkin lymphoma registryValeria Buccheri, Frederico Rafael Moreira, Irene Biasoli, et al.
Hematological Oncology|June 24, 2017
Treatment outcomes for Hodgkin lymphoma: First report from the Brazilian Prospective RegistryIrene Biasoli, Nelson Castro, Marcia Delamain, et al.
International Journal of Cancer|October 13, 2017
Lower socioeconomic status is independently associated with shorter survival in Hodgkin Lymphoma patients-An analysis from the Brazilian Hodgkin Lymphoma RegistryIrene Biasoli, Nelson Castro, Marcia Delamain, et al.
Annals of Hematology|July 20, 2023
Treatment patterns and outcomes for Hodgkin Lymphoma patients aged 60 and older: a report from the Brazilian Prospective Hodgkin Lymphoma RegistryLilian Goveia, Nelson Castro, Carmino de Souza, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
American Journal of Hematology|May 23, 2022
Isatuximab plus carfilzomib and dexamethasone in patients with relapsed multiple myeloma based on prior lines of treatment and refractory status: IKEMA subgroup analysisMeletios A Dimopoulos, Philippe Moreau, Bradley Augustson, et al.
Ejhaem|November 29, 2023
Treatment outcomes in classic Hodgkin lymphoma: 5-year update from the Brazilian Hodgkin Lymphoma RegistryIrene Biasoli, Nelson Castro, Carolina Colaço Villarim, et al.
British Journal of Haematology|October 17, 2024
External validation and calibration of the HoLISTIC Consortium's advanced-stage Hodgkin lymphoma international prognostic index (A-HIPI) in the Brazilian Hodgkin lymphoma registryValeria Buccheri, Frederico Rafael Moreira, Irene Biasoli, et al.
Hematological Oncology|June 24, 2017
Treatment outcomes for Hodgkin lymphoma: First report from the Brazilian Prospective RegistryIrene Biasoli, Nelson Castro, Marcia Delamain, et al.
International Journal of Cancer|October 13, 2017
Lower socioeconomic status is independently associated with shorter survival in Hodgkin Lymphoma patients-An analysis from the Brazilian Hodgkin Lymphoma RegistryIrene Biasoli, Nelson Castro, Marcia Delamain, et al.
Annals of Hematology|July 20, 2023
Treatment patterns and outcomes for Hodgkin Lymphoma patients aged 60 and older: a report from the Brazilian Prospective Hodgkin Lymphoma RegistryLilian Goveia, Nelson Castro, Carmino de Souza, et al.
Pageof 2